Does interferon and ribavirin combination therapy increase the rate of treatment response in children with hepatitis C?

Suoglu O., Elkabes B., Sokucu S., Saner G.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, vol.34, no.2, pp.199-206, 2002 (SCI-Expanded) identifier identifier identifier


Background: Interferon-alpha was the first accepted treatment of chronic hepatitis C. In recent years, adding ribavirin has produced better response rates in adult patients than monotherapy with interferon-alpha. Whether adding ribavirin also improves treatment results in pediatric patients remains unclear.